Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take a statin for cholesterol and you're considering Mounjaro for weight management, the most important thing to know upfront is this: tirzepatide (Mounjaro) is not generally contraindicated with statins, and many people take both medicines concurrently under clinical supervision. That said, a prescriber needs to review your full medication list before treatment begins, because some individual considerations are worth discussing carefully. These are prescription-only medicines, and the decision always rests with a clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A surprisingly common worry among people already on statins is that Mounjaro is simply off-limits for them, or that starting it means immediately stopping their cholesterol medicine. That's not what the clinical evidence or prescribing guidance says. The two medicines target different systems entirely: statins inhibit an enzyme in the liver involved in cholesterol synthesis, while tirzepatide activates GIP and GLP-1 receptors involved in appetite, blood-sugar regulation and gastric motility. There is no known pharmacological reason these mechanisms should clash.
The NHS medicines page for tirzepatide does not list statins as a class of medicines to avoid. What it does flag is the importance of telling your prescriber and pharmacist about every medicine you take, including over-the-counter and herbal products, before starting treatment. That's the right starting point, not anxiety about a blanket ban.
Some people find it reassuring to hear that this question comes up regularly in clinical practice. If you're sitting with a list of repeat prescriptions in hand, wondering whether any of them rules Mounjaro out, that's a completely understandable place to be.
Here is something worth understanding before any prescriber conversation: weight loss itself tends to improve cholesterol profiles. Clinical trial data from the SURMOUNT programme showed meaningful reductions in body weight for participants taking tirzepatide across thousands of adults, and falling weight is well associated with falling LDL cholesterol and triglycerides, alongside improvements in HDL. You can find a detailed look at those Mounjaro trial statistics if you want the numbers.
What this means practically is that your statin needs may change over time as your weight falls and your lipid profile shifts. That isn't a problem with taking both medicines; it's a reason to keep your GP in the loop, so that your statin dose can be reviewed periodically. A prescriber might reduce your statin, maintain it, or in some cases stop it altogether if your cardiovascular risk profile improves sufficiently. None of that happens automatically or at your own initiative — it happens through reviewed clinical decisions.
If you'd like to understand tirzepatide's broader mechanism and licensed uses in more depth, our tirzepatide overview page covers the dual GIP and GLP-1 receptor pathway in plain language.
This is a legitimate clinical question, not a myth to dismiss. Mounjaro does slow gastric emptying, which is part of how it reduces appetite. For oral medicines that rely on rapid absorption from the stomach, that delay can theoretically affect how much reaches the bloodstream, and how quickly. The Mounjaro SmPC discusses this, and the NHS tirzepatide page notes that it can affect the absorption of other medicines taken by mouth.
Statins vary. Some, like atorvastatin, are typically taken in the evening and absorbed over a longer window; others have different absorption characteristics. The clinical consensus is not that statins should be abandoned, but that timing and dose may be worth discussing with a prescriber, particularly for anyone already on a narrow-therapeutic-index medicine taken orally. Practically, many people on statins and Mounjaro together report no problems, especially when the two are taken at different times of day.
If atorvastatin specifically is part of your regime, our page on taking Mounjaro with atorvastatin goes into further detail on what to watch for. And for a broader look at how the interaction question is framed clinically, see our page on Mounjaro and statins.
The practical steps are straightforward. Tell your prescriber about your statin, the dose you're on, and when you take it. If you have recent lipid results, those are useful context. Your prescriber can then make a fully informed assessment rather than one based on incomplete information.
At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber before anything is approved — a real clinician reads your answers, not software. Our clinical team is experienced with exactly these kinds of multi-medicine reviews. If you're managing other health conditions alongside weight, it can also be worth reading about Mounjaro considerations for older adults, where polypharmacy questions come up more frequently.
Mounjaro is a prescription-only medicine licensed for weight management in adults. A prescriber decides suitability after reviewing your full history, including any statins or other regular medicines. If you'd like that review, you can explore your options on our treatment page and start your free consultation there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.